Skip to main content
Top
Published in: BMC Nephrology 1/2011

Open Access 01-12-2011 | Study protocol

Design and implementation of the canadian kidney disease cohort study (CKDCS): A prospective observational study of incident hemodialysis patients

Authors: Aminu K Bello, Ravi Thadhani, Brenda Hemmelgarn, Scott Klarenbach, John Gill, Christopher Chan, Deborah Zimmerman, Daniel Holmes, George Cembrowski, Dawn Opgenorth, Rafael Sibrian, Mohammad Karkhaneh, Sophanny Tiv, Natasha Wiebe, Marcello Tonelli

Published in: BMC Nephrology | Issue 1/2011

Login to get access

Abstract

Background

Many nephrology observational studies use renal registries, which have well known limitations. The Canadian Kidney Disease Cohort Study (CKDCS) is a large prospective observational study of patients commencing hemodialysis in five Canadian centers. This study focuses on delineating potentially reversible determinants of adverse outcomes that occur in patients receiving dialysis for end-stage renal disease (ESRD).

Methods/Design

The CKDCS collects information on risk factors and outcomes, and stores specimens (blood, dialysate, hair and fingernails) at baseline and in long-term follow-up. Such specimens will permit measurements of biochemical markers, proteomic and genetic parameters (proteins and DNA) not measured in routine care. To avoid selection bias, all consenting incident hemodialysis patients at participating centers are enrolled, the large sample size (target of 1500 patients), large number of exposures, and high event rates will permit the exploration of multiple potential research questions.

Preliminary Results

Data on the baseline characteristics from the first 1074 subjects showed that the average age of patients was 62 (range; 50-73) years. The leading cause of ESRD was diabetic nephropathy (41.9%), and the majority of the patients were white (80.0%). Only 18.7% of the subjects received dialysis in a satellite unit, and over 80% lived within a 50 km radius of the nearest nephrologist's practice.

Discussion

The prospective design, detailed clinical information, and stored biological specimens provide a wealth of information with potential to greatly enhance our understanding of risk factors for adverse outcomes in dialysis patients. The scientific value of the stored patient tissue will grow as new genetic and biochemical markers are discovered in the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, et al: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007, 72 (3): 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, et al: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007, 72 (3): 247-259. 10.1038/sj.ki.5002343.CrossRefPubMed
2.
go back to reference Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet. 2005, 365 (9456): 331-340.CrossRefPubMed Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet. 2005, 365 (9456): 331-340.CrossRefPubMed
3.
go back to reference Snyder JJ, Collins AJ: KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol. 2009, 30 (1): 44-54. 10.1159/000201014.CrossRefPubMed Snyder JJ, Collins AJ: KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004. Am J Nephrol. 2009, 30 (1): 44-54. 10.1159/000201014.CrossRefPubMed
5.
go back to reference Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al: United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis. 2009, 53 (1 Suppl): S1-374. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, et al: United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis. 2009, 53 (1 Suppl): S1-374.
6.
go back to reference De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999, 14 (Suppl 6): 31-41. 10.1093/ndt/14.suppl_6.31.CrossRefPubMed De Vecchi AF, Dratwa M, Wiedemann ME: Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant. 1999, 14 (Suppl 6): 31-41. 10.1093/ndt/14.suppl_6.31.CrossRefPubMed
7.
go back to reference Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ: Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003, 64 (5): 1903-1910. 10.1046/j.1523-1755.2003.00289.x.CrossRefPubMed Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ: Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003, 64 (5): 1903-1910. 10.1046/j.1523-1755.2003.00289.x.CrossRefPubMed
9.
go back to reference Manns B, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C: Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants?. Clin Nephrol. 2003, 60 (5): 341-351.CrossRefPubMed Manns B, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C: Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants?. Clin Nephrol. 2003, 60 (5): 341-351.CrossRefPubMed
10.
go back to reference McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003, 64 (3): 1004-1011. 10.1046/j.1523-1755.2003.00157.x.CrossRefPubMed McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003, 64 (3): 1004-1011. 10.1046/j.1523-1755.2003.00157.x.CrossRefPubMed
11.
go back to reference Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010, 21 (3): 499-506. 10.1681/ASN.2009060635.CrossRefPubMedPubMedCentral Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010, 21 (3): 499-506. 10.1681/ASN.2009060635.CrossRefPubMedPubMedCentral
12.
go back to reference Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman HI, Goodkin DA, et al: Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004, 19 (1): 108-120. 10.1093/ndt/gfg483.CrossRefPubMed Rayner HC, Pisoni RL, Bommer J, Canaud B, Hecking E, Locatelli F, Piera L, Bragg-Gresham JL, Feldman HI, Goodkin DA, et al: Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004, 19 (1): 108-120. 10.1093/ndt/gfg483.CrossRefPubMed
14.
go back to reference Ronco P: Disease classification: a pitfall of the ERA/EDTA registry?. Nephrol Dial Transplant. 2010, 25 (4): 1022-1024. 10.1093/ndt/gfq022.CrossRefPubMed Ronco P: Disease classification: a pitfall of the ERA/EDTA registry?. Nephrol Dial Transplant. 2010, 25 (4): 1022-1024. 10.1093/ndt/gfq022.CrossRefPubMed
16.
go back to reference Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004, 44 (5 Suppl 2): 7-15. 10.1016/S0272-6386(04)01099-6.CrossRefPubMed Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004, 44 (5 Suppl 2): 7-15. 10.1016/S0272-6386(04)01099-6.CrossRefPubMed
17.
go back to reference Sozio SM, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, Powe NR, Parekh RS: Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 2009, 54 (3): 468-477. 10.1053/j.ajkd.2009.01.261.CrossRefPubMedPubMedCentral Sozio SM, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, Powe NR, Parekh RS: Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 2009, 54 (3): 468-477. 10.1053/j.ajkd.2009.01.261.CrossRefPubMedPubMedCentral
18.
go back to reference van der Bijl N, Joemai RM, Geleijns J, Bax JJ, Schuijf JD, de Roos A, Kroft LJ: Assessment of Agatston coronary artery calcium score using contrast-enhanced CT coronary angiography. AJR Am J Roentgenol. 2010, 195 (6): 1299-1305. 10.2214/AJR.09.3734.CrossRefPubMed van der Bijl N, Joemai RM, Geleijns J, Bax JJ, Schuijf JD, de Roos A, Kroft LJ: Assessment of Agatston coronary artery calcium score using contrast-enhanced CT coronary angiography. AJR Am J Roentgenol. 2010, 195 (6): 1299-1305. 10.2214/AJR.09.3734.CrossRefPubMed
19.
go back to reference Mermel LA: Prevention of intravascular catheter infections--insights and prospects for hemodialysis catheters. Nephrologie. 2001, 22 (8): 449-451.PubMed Mermel LA: Prevention of intravascular catheter infections--insights and prospects for hemodialysis catheters. Nephrologie. 2001, 22 (8): 449-451.PubMed
20.
go back to reference Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS: Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. Am J Kidney Dis. 2002, 39 (1): 146-153. 10.1053/ajkd.2002.29905.CrossRefPubMed Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS: Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. Am J Kidney Dis. 2002, 39 (1): 146-153. 10.1053/ajkd.2002.29905.CrossRefPubMed
21.
go back to reference Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002, 347 (25): 2010-2019. 10.1056/NEJMoa021583.CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002, 347 (25): 2010-2019. 10.1056/NEJMoa021583.CrossRefPubMed
22.
go back to reference Quan H, Khan N, Hemmelgarn BR, Tu K, Chen G, Campbell N, Hill MD, Ghali WA, McAlister FA: Validation of a case definition to define hypertension using administrative data. Hypertension. 2009, 54 (6): 1423-1428. 10.1161/HYPERTENSIONAHA.109.139279.CrossRefPubMed Quan H, Khan N, Hemmelgarn BR, Tu K, Chen G, Campbell N, Hill MD, Ghali WA, McAlister FA: Validation of a case definition to define hypertension using administrative data. Hypertension. 2009, 54 (6): 1423-1428. 10.1161/HYPERTENSIONAHA.109.139279.CrossRefPubMed
23.
go back to reference Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002, 25 (3): 512-516. 10.2337/diacare.25.3.512.CrossRefPubMed
24.
go back to reference Austin PC, Daly PA, Tu JV: A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002, 144 (2): 290-296. 10.1067/mhj.2002.123839.CrossRefPubMed Austin PC, Daly PA, Tu JV: A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002, 144 (2): 290-296. 10.1067/mhj.2002.123839.CrossRefPubMed
25.
go back to reference Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV: Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005, 43 (2): 182-188. 10.1097/00005650-200502000-00012.CrossRefPubMed Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL, Tu JV: Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005, 43 (2): 182-188. 10.1097/00005650-200502000-00012.CrossRefPubMed
26.
go back to reference Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005, 36 (8): 1776-1781. 10.1161/01.STR.0000174293.17959.a1.CrossRefPubMed Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005, 36 (8): 1776-1781. 10.1161/01.STR.0000174293.17959.a1.CrossRefPubMed
27.
go back to reference Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, et al: Overview of the Alberta Kidney Disease Network. BMC Nephrol. 2009, 10: 30-10.1186/1471-2369-10-30.CrossRefPubMedPubMedCentral Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, et al: Overview of the Alberta Kidney Disease Network. BMC Nephrol. 2009, 10: 30-10.1186/1471-2369-10-30.CrossRefPubMedPubMedCentral
28.
go back to reference Heng D, Pong RW, Pitblado JR, Lagace C, Desmeules M: Sources of data for rural health research: development of an inventory of Canadian databases. J Agric Saf Health. 2005, 11 (2): 219-227.CrossRefPubMed Heng D, Pong RW, Pitblado JR, Lagace C, Desmeules M: Sources of data for rural health research: development of an inventory of Canadian databases. J Agric Saf Health. 2005, 11 (2): 219-227.CrossRefPubMed
29.
go back to reference Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW: The randomized clinical trial: an unbeatable standard in clinical research?. Kidney Int. 2007, 72 (5): 539-542. 10.1038/sj.ki.5002354.CrossRefPubMed Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW: The randomized clinical trial: an unbeatable standard in clinical research?. Kidney Int. 2007, 72 (5): 539-542. 10.1038/sj.ki.5002354.CrossRefPubMed
30.
go back to reference Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW: The valuable contribution of observational studies to nephrology. Kidney Int. 2007, 72 (6): 671-675. 10.1038/sj.ki.5002397.CrossRefPubMed Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW: The valuable contribution of observational studies to nephrology. Kidney Int. 2007, 72 (6): 671-675. 10.1038/sj.ki.5002397.CrossRefPubMed
31.
go back to reference Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002, 13 (5): 1307-1320.PubMed Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002, 13 (5): 1307-1320.PubMed
32.
go back to reference Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C: Bias in clinical research. Kidney Int. 2008, 73 (2): 148-153. 10.1038/sj.ki.5002648.CrossRefPubMed Tripepi G, Jager KJ, Dekker FW, Wanner C, Zoccali C: Bias in clinical research. Kidney Int. 2008, 73 (2): 148-153. 10.1038/sj.ki.5002648.CrossRefPubMed
33.
go back to reference Hong KW, Oh B: Overview of personalized medicine in the disease genomic era. BMB Rep. 2010, 43 (10): 643-648. 10.5483/BMBRep.2010.43.10.643.CrossRefPubMed Hong KW, Oh B: Overview of personalized medicine in the disease genomic era. BMB Rep. 2010, 43 (10): 643-648. 10.5483/BMBRep.2010.43.10.643.CrossRefPubMed
34.
go back to reference Ding L, Wendl MC, Koboldt DC, Mardis ER: Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet. 2010, 19 (R2): R188-196. 10.1093/hmg/ddq391.CrossRefPubMedPubMedCentral Ding L, Wendl MC, Koboldt DC, Mardis ER: Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum Mol Genet. 2010, 19 (R2): R188-196. 10.1093/hmg/ddq391.CrossRefPubMedPubMedCentral
35.
go back to reference Borovecki F, Habek M: Development of novel genomic blood biomarkers for neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2010, 9 (6): 669-678.CrossRefPubMed Borovecki F, Habek M: Development of novel genomic blood biomarkers for neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2010, 9 (6): 669-678.CrossRefPubMed
Metadata
Title
Design and implementation of the canadian kidney disease cohort study (CKDCS): A prospective observational study of incident hemodialysis patients
Authors
Aminu K Bello
Ravi Thadhani
Brenda Hemmelgarn
Scott Klarenbach
John Gill
Christopher Chan
Deborah Zimmerman
Daniel Holmes
George Cembrowski
Dawn Opgenorth
Rafael Sibrian
Mohammad Karkhaneh
Sophanny Tiv
Natasha Wiebe
Marcello Tonelli
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2011
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-12-10

Other articles of this Issue 1/2011

BMC Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.